Neurotech International (NTI) Stock Statistics & Valuation Metrics

Neurotech International has a market cap or net worth of AU$18.89M. The enterprise value is AU$28.94M.

Neurotech International has 1,049,622,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Neurotech International’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -43.42%.

The current PE Ratio of Neurotech International is -12.77. Neurotech International’s PEG ratio is -0.04.

In the last 12 months, Neurotech International had revenue of 1.96K and earned -5.07M in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was -9.82M and capital expenditures 0.00, giving a free cash flow of -9.82M billion.

Neurotech International pays an annual dividend of ―, resulting in a dividend yield of ―

Neurotech International upcoming earnings date is Aug 27, 2025, TBA (Confirmed).

Neurotech International as a current ratio of 38.81, with Debt / Equity ratio of 0.00%

In the past 12 months, Neurotech International has paid -3.18M in taxes.

Neurotech International EV to EBITDA ratio is -6.44, with an EV/FCF ratio of -11.56.

Neurotech International has AU$5.96M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -AU$5.96M billion.

Gross margin is 70.73%, with operating margin of -428057.67%, and net profit margin of -258239.99%.

The average price target for Neurotech International is ―, which is 11.43% higher than the current price. The consensus rating is ―